PF614 capsule

DRUG2 trials

Sponsors

Ensysce Biosciences

Conditions

Healthy VolunteerPharmacokineticsPostoperative Pain, Acute

Phase 1

Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)

RecruitingNCT06500793

Ensysce BiosciencesHealthy Volunteer, Pharmacokinetics

Start: 2024-11-24End: 2027-04-28Target: 54Updated: 2026-05-26

Phase 3

PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)

RecruitingNCT06602271

Ensysce BiosciencesPostoperative Pain, Acute

Start: 2025-12-09End: 2026-11-01Target: 320Updated: 2026-01-22